BioSpace News Archive

Biotech Bay

Harpoon Therapeutics to Participate in Canaccord Genuity Horizons in Oncology Virtual Conference

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company developing novel T cell engagers, announced that management will participate in a fireside chat at the Canaccord Genuity Horizons in Oncology Virtual Conference.

April 7, 2022
·
1 min read
Cognitive and Memory Enhancer Drugs Market – Growth Expansion Opportunities in the Global Market

The cognitive and memory enhancer drugs market has been anticipated to grow at a significant pace throughout the forecast period.

April 7, 2022
·
5 min read
Capnography Devices Market: Rapid growth in respiratory diseases to drive the market

Albany NY, United States: Substantial evidence of efficacy of capnography to measure the concentration of CO2 in respiratory gases to investigate several respiratory diseases is promising for the demand of capnography devices.

April 7, 2022
·
6 min read
Hormonal Contraceptives Market New Development and Growth Opportunity in the Industry – Global Analysis Report

The hormonal contraceptives market has been anticipated to grow at a significant pace throughout the forecast period.

April 7, 2022
·
5 min read
Surgical Simulation Market: Rising popularity of various surgical procedures to drive the market

Albany NY, United States: The surgical simulation market is estimated to observe a positive growth trajectory across the assessment period of 2019-2027.

April 7, 2022
·
6 min read
Point of Care Ultrasound Market: Increase in cardiovascular disorders and chronic diseases to drive the market

Albany NY, United States: The increasing geriatric population and the overwhelming demand for portable devices used for diagnostic and therapeutic purposes are vital factors that will have a positive impact on the growth of the point of care ultrasound market during the forecast period of 2019-2027.

April 7, 2022
·
6 min read
Business

Onxeo Appoints Dr. Shefali Agarwal as President and Chief Executive Officer

Onxeo S.A., hereafter “Onxeo” or the “Company”, a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response, announced the appointment of Dr. Shefali Agarwal as President and Chief Executive Officer.

April 7, 2022
·
6 min read
Drug Development

ABIONYX Pharma Reports Positive Interim Results From Phase 2a Clinical Trial Evaluating CER-001 in the Treatment of Septic Patients at High Risk of Developing Acute Kidney Injury

ABIONYX Pharma reported positive interim results of an open-label Phase 2a clinical trial evaluating CER-001 as a treatment for septic patients at high risk of developing Acute Kidney Injury.

April 7, 2022
·
3 min read
Business

Hansa Biopharma publishes Annual Report 2021

Hansa Biopharma AB “Hansa”, a pioneer in enzyme technology for rare immunological conditions, announced the release of the Annual Report 2021

April 7, 2022
·
7 min read
Drug Development

iOmx to Present New Pre-Clinical Data on SIK3 Checkpoint Inhibitor OMX-0407 at AACR 2022

iOmx Therapeutics AG, a biopharmaceutical company developing cancer therapeutics based on next-generation immune checkpoint targets, announced the presentation of new preclinical data for its lead program IMT-07 with product candidate OMX-0407, a first-in-class oral SIK3 inhibitor.

April 7, 2022
·
3 min read